Market Research Logo

European Product Portfolio for Vascular Access Devices and Accessories 2017 - MedFolio

European Product Portfolio for Vascular Access Devices and Accessories 2017 - MedFolio

Europe-wide legislation encouraging the use of safety devices implemented in 2013 and early 2014 have been transposed in all countries included in this report. In addition, regions in Europe have passed their own laws to promote the use of safety devices such as syringes and needles in the workplace. Safety products carry a significant price premium compared to conventional products; the higher ASPs of these safety devices have increased the value of the market, and ongoing conversion is expected to boost future growth. While the conversion to the use of safety needles and PIVCs is taking place in Europe following the introduction of the directive by the Council of the European Union, lack of enforcement by local authorities will hinder the conversion to safety devices. In 2016, it was estimated that approximately 90% of patients who were hospitalized in the Western European region received vascular access treatment during their stay. The ability to infuse medications or fluids into a patient’s bloodstream is indispensable to modern medicine. Vascular access devices include peripheral intravenous catheters (PIVCs), peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports, Huber needles, dialysis catheters, manufactured catheter securement devices and syringes and needles. The European market for vascular access devices and accessories includes Germany, France, Italy, the United Kingdom, Spain, Benelux (the Netherlands, Belgium and Luxembourg), Scandinavia (Sweden, Norway, Denmark and Finland), Portugal, Austria and Switzerland.

The full report suite on the European market for vascular access devices and accessories includes implantable ports, port needles, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), dialysis catheters, manufactured catheter securement devices (MCSDs) and syringes and needles. Vascular access devices are used for gaining access to a patient’s bloodstream via the veins. They can deliver a wide range of treatments, including fluid infusion, blood draws, parenteral nutrition, antibiotics, chemotherapy and dialysis. The duration of treatment lasts anywhere from hours to years, depending on the type of vascular access device used and the type of medication that is being infused.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Human Vascular System
2.2 VASCULAR PATHOLOGY AND DISORDERS
2.2.1 Cancer
2.2.2 End-Stage Renal Disease
2.2.3 Diabetes
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Implantable Port Devices
3.1.1.1 Introduction
3.1.1.1.1 Implantable Port Patients
3.1.1.1.2 Port Implantation Procedures
3.1.1.1.3 Port Infusion
3.1.1.1.4 Port Maintenance
3.1.1.2 AngioDynamics
3.1.1.2.1 BioFlo®
3.1.1.2.2 LifePort®
3.1.1.2.3 Smart Port® CT
3.1.1.2.4 TitanPort®
3.1.1.2.5 Triumph-1®
3.1.1.2.6 Vortex®
3.1.1.2.7 Xcela™ Plus
3.1.1.3 B. Braun
3.1.1.3.1 Celsite®
3.1.1.4 Cook Medical
3.1.1.4.1 Vital-Port®
3.1.1.5 C.R. Bard
3.1.1.5.1 PowerPort®
3.1.1.5.2 SlimPort®
3.1.1.5.3 X-Port™
3.1.1.5.4 Other Port Offerings
3.1.1.6 Medcomp
3.1.1.6.1 Dignity®
3.1.1.6.2 Pro-Fuse® CT
3.1.1.7 PFM Medical
3.1.1.7.1 T-Port™
3.1.1.7.2 TitaJet™
3.1.1.7.3 Jet Port®
3.1.1.7.4 DualPort
3.1.1.8 Smiths Medical
3.1.1.8.1 P.A.S. PORT®
3.1.1.8.2 PORT-A-CATH®
3.1.1.9 Teleflex Medical
3.1.1.9.1 Polysite®
3.1.2 Port Needles
3.1.2.1 Introduction
3.1.2.2 AngioDynamics
3.1.2.2.1 LifeGuard®
3.1.2.2.2 LifePort®
3.1.2.3 B. Braun
3.1.2.3.1 WHIN®
3.1.2.4 Cook Medical
3.1.2.4.1 Vital-Ject™
3.1.2.5 C. R. Bard
3.1.2.5.1 PowerLoc®
3.1.2.5.2 Other Port Needle Offerings
3.1.2.6 Kawasumi
3.1.2.6.1 K-Shield®
3.1.2.6.2 Other Port Needle Offerings
3.1.2.7 MPS Medical, Inc.
3.1.2.7.1 SmartSafety®
3.1.2.8 Nipro Medical
3.1.2.8.1 SafeTouch™
3.1.2.9 Smiths Medical
3.1.2.9.1 GRIPPER®
3.1.2.9.2 GRIPPER PLUS®
3.1.2.9.3 Other Port Needle Offerings
3.1.2.10 Vygon (Churchill Medical Systems)
3.1.2.10.1 LifeGuard™
3.1.2.10.2 Wing Safe™
3.1.3 Central Venous Catheters
3.1.3.1 Introduction
3.1.3.1.1 CVC Procedures
3.1.3.1.2 CVC Kits
3.1.3.1.3 CVC Market Segments
3.1.3.2 AngioDynamics
3.1.3.2.1 NeoStar™
3.1.3.3 Centurion Medical Products
3.1.3.3.1 Vantex™
3.1.3.3.2 Multi-Med™
3.1.3.3.3 AVA™
3.1.3.4 Cook Medical
3.1.3.4.1 Spectrum®
3.1.3.5 C.R. Bard
3.1.3.5.1 PowerHohn®
3.1.3.5.2 Hohn®
3.1.3.5.3 Other CVC Offerings
3.1.3.6 Medcomp Inc.
3.1.3.6.1 Pro-Line®
3.1.3.6.2 Vascu-Line®
3.1.3.6.3 Other CVC Offerings
3.1.3.7 Teleflex Medical
3.1.3.7.1 Standard
3.1.3.7.2 ARROWg+ard Blue®
3.1.3.7.3 ARROWg+ard Blue Plus®
3.1.3.7.4 Chlorag+ard®
3.1.4 Peripherally Inserted Central Catheters
3.1.4.1 Introduction
3.1.4.1.1 PICC Placement
3.1.4.2 AngioDynamics
3.1.4.2.1 BioFlo®
3.1.4.3 Argon Medical
13.1.4.3.1 First PICC™
3.1.4.3.2 L-Cath™
3.1.4.4 B. Braun
3.1.4.4.1 V-5™
3.1.4.4.2 Other PICC Offerings
3.1.4.5 Cook Medical
3.1.4.5.1 Spectrum®
3.1.4.5.2 Other PICC Offerings
3.1.4.6 C.R. Bard
3.1.4.6.1 PowerPICC®
3.1.4.6.2 Groshong®
3.1.4.6.3 Per-Q-Cath®
3.1.4.6.4 Other PICC Offerings
3.1.4.7 GaltNeedleTech
3.1.4.7.1 SYNERGY™
3.1.4.8 Medcomp
3.1.4.8.1 Pro-PICC™
3.1.4.8.2 Vascu-PICC™
3.1.4.9 Neo Medical
3.1.4.9.1 Neo-Magic™
3.1.4.9.2 V-Cath™
3.1.4.10 PFM Medical
3.1.4.10.1 pfm CT PICC II
3.1.4.11 Teleflex Medical
3.1.4.11.1 ARROW®
3.1.4.12 Trinity Sterile
3.1.4.12.1 Trinity™ PICC II
3.1.4.13 Vygon
3.1.4.13.1 Premicath™
3.1.4.13.2 Epicutaneo-Cava™
3.1.4.13.3 Nutriline™
3.1.4.13.4 Lifecath™
3.1.5 Peripheral Intravenous Catheters
3.1.5.1 Introduction
3.1.5.2 Access Scientific
3.1.5.2.1 POWERWAND®
3.1.5.3 AngioDynamics
3.1.5.3.1 BioFlo®
3.1.5.4 Argon Medical
3.1.5.4.1 First Midcath™
3.1.5.4.2 L-Cath™
3.1.5.5 B. Braun
3.1.5.5.1 Introcan Safety®
3.1.5.6 Becton Dickinson
3.1.5.6.1 Nexiva™
3.1.5.6.2 Saf-T-Intima™
3.1.5.6.3 Autoguard™
3.1.5.7 C.R. Bard
3.1.5.7.1 AccuCath®
3.1.5.7.2 PowerGlide®
3.1.5.7.3 Bard® Poly
3.1.5.7.4 Other Midline Offerings
3.1.5.8 GaltNeedleTech
3.1.5.8.1 Nexus™
3.1.5.9 Medcomp
3.1.5.9.1 Medcomp® Midline
3.1.5.10 MediKit
3.1.5.10.1 Supercath™
3.1.5.11 Neo Medical
3.1.5.11.1 PowerStick™
3.1.5.11.2 Neo-Magic®
3.1.5.12 Nipro Medical
3.1.5.12.1 Nipro™ IV Catheter
3.1.5.13 Retractable Technologies, Inc.
3.1.5.13.1 VanishPoint®
3.1.5.14 Smiths Medical
3.1.5.14.1 ViaValve™
3.1.5.14.2 PROTECTIV®
3.1.5.14.3 ACUVANCE®
3.1.5.14.4 Other PIVC offerings
3.1.5.15 Tangent Medical
3.1.5.15.1 NovaCath™
3.1.5.16 Teleflex Medical
3.1.5.16.1 ARROW®
3.1.5.16.2 TwinCath®
3.1.5.17 Terumo
3.1.5.17.1 SurFlash®
3.1.5.17.2 SURFLO®
3.1.5.18 Vygon
3.1.5.18.1 Leader-Flex™
3.1.6 Dialysis Catheters
3.1.6.1 Introduction
3.1.6.1.1 AV Fistulae
3.1.6.1.2 AV Grafts
3.1.6.1.3 Dialysis Catheters
3.1.6.2 AngioDynamics
3.1.6.2.1 DuraMax®
3.1.6.2.2 DuraFlow™
3.1.6.2.3 Schon™
3.1.6.2.4 Other Dialysis Catheter Offerings
3.1.6.3 Argon Medical
3.1.6.3.1 UltraStream™
3.1.6.4 Baxter
3.1.6.4.1 GamCath™
3.1.6.5 Cook Medical
3.1.6.5.1 Turbo-Flo®
3.1.6.5.2 Tenckhoff™
3.1.6.6 C.R. Bard
3.1.6.6.1 EQUISTREAM®
3.1.6.6.2 HemoSplit®
3.1.6.6.3 HemoStar®
3.1.6.6.4 Niagara™
3.1.6.6.5 Other Dialysis Catheter Offerings
3.1.6.7 Marvao Medical
3.1.6.7.1 NexSite™
3.1.6.8 Medcomp
3.1.6.8.1 Split Cath®
3.1.6.8.2 Hemo-Cath®
3.1.6.8.3 Hemo-Flow®
3.1.6.8.4 Other Dialysis Catheter Offerings
3.1.6.9 Medtronic
3.1.6.9.1 MAHURKAR™
3.1.6.9.2 Palindrome™
3.1.6.9.3 Other Dialysis Catheter Offerings
3.1.6.10 Merit Medical
3.1.6.10.1 Flex-Neck®
3.1.6.10.2 Centros™
3.1.6.10.3 ProGuide™
3.1.6.11 PFM Medical
3.1.6.11.1 Veta™
3.1.6.12 Phase One Medical
3.1.6.12.1 Symetrex™
3.1.6.13 Teleflex Medical
3.1.6.13.1 NextStep®
3.1.6.13.2 VectorFlow™
3.1.6.13.3 Other Dialysis Catheter Offerings
3.1.7 Ultrasound Vascular Access Devices
3.1.7.1 Introduction
3.1.7.1.1 Alternates to Ultrasound Guidance
3.1.7.1.2 Ultrasound Guidance
3.1.7.1.3 Ultrasound Vessel Mapping
3.1.7.1.4 Tip Location
3.1.7.1.5 General Ultrasound Imaging Systems with Vascular Access Guidance Capabilities Market
3.1.7.2 Analogic
3.1.7.2.1 Sonic Window™
3.1.7.3 AngioDynamics
3.1.7.3.1 Celerity™
3.1.7.4 Chison
3.1.7.4.1 EC0™
3.1.7.4.2 Other Ultrasound Offerings
3.1.7.5 C.R. Bard
3.1.7.5.1 Site~Rite®
3.1.7.5.2 Sherlock®
3.1.7.6 Esaote North America
3.1.7.6.1 MyLab™
3.1.7.7 eZono
3.1.7.7.1 eZono®
3.1.7.8 FUJIFILM SonoSite, Inc.
3.1.7.8.1 S Series™
3.1.7.8.2 NanoMaxx®
3.1.7.8.3 Edge® II
3.1.7.8.4 M-Turbo®
3.1.7.8.5 iViz®
3.1.7.9 GE Healthcare
3.1.7.9.1 Vscan™
3.1.7.9.2 LOGIQ™
3.1.7.9.3 Venue™
3.1.7.10 Konica Minolta
3.1.7.10.1 Sonimage™ P3
3.1.7.11 Medcomp
3.1.7.11.1 Navigator® BioNavigation™
3.1.7.12 Mobisante
3.1.7.12.1 MobiUS™
3.1.7.13 Philips
3.1.7.13.1 Lumify™
3.1.7.14 Romedex
3.1.7.14.1 Nautilus™
3.1.7.15 Siemens
3.1.7.15.1 ACUSON™
3.1.7.16 SIUI
3.1.7.16.1 Apogee™
3.1.7.16.2 CTS™
3.1.7.17 SonoScape
3.1.7.17.1 S™
3.1.7.17.2 A™
3.1.7.18 Teleflex Medical
3.1.7.18.1 ARROW® VPS®
3.1.7.19 Terason
3.1.7.19.1 uSmart®
3.1.7.20 Toshiba
3.1.7.20.1 Viamo™
3.1.7.21 Zonare
3.1.7.21.1 M™
3.1.7.21.2 Other Ultrasound Offerings
3.1.8 Catheter Securement Devices
3.1.8.1 Introduction
3.1.8.1.1 Catheter Stabilization Methods
3.1.8.2 3M
3.1.8.2.1 3M™ PICC/CVC Securement Systems
3.1.8.2.2 Tegaderm™
3.1.8.2.3 3M™ Medical Tapes
3.1.8.3 Baxter
3.1.8.3.1 VITAL-HOLD™
3.1.8.4 Cardinal Health
3.1.8.4.1 Original Boarder
3.1.8.4.2 Advanced IV
3.1.8.5 Centurion Medical
3.1.8.5.1 SorbaView®
3.1.8.5.2 Other Product Offerings
3.1.8.6 C.R. Bard
3.1.8.6.1 StatLock® IV
3.1.8.6.2 StatLock® PICC
3.1.8.6.3 StatLock® CV
3.1.8.6.4 StatLock® Dialysis
3.1.8.6.5 Other StatLock® Offerings
3.1.8.7 Insightra Medical
3.1.8.7.1 Modulare®
3.1.8.8 Interrad Medical
3.1.8.8.1 SecurAcath®
3.1.8.9 Johnson & Johnson
3.1.8.9.1 BioPatch®
3.1.8.9.2 Other Product Offerings
3.1.8.10 M.C. Johnson
3.1.8.10.1 CATH-SECURE™
3.1.8.11 Medtronic
3.1.8.11.1 Kendall™
3.1.8.11.2 Other Product Offerings
3.1.8.12 Neo Medical
3.1.8.12.1 V-Lock™
3.1.8.13 Smith & Nephew
3.1.8.13.1 IV3000®
3.1.8.13.2 HYPAFIX®
3.1.8.13.3 PRIMAPORE®
3.1.8.14 Starboard Medical
3.1.8.14.1 CLIK-IT™
3.1.8.15 TIDI Products
3.1.8.15.1 Grip-Lok® PICC Securement
3.1.8.15.2 Grip-Lok® CVC Securement
3.1.8.15.3 Grip-Lok® PIVC Securement
3.1.9 Syringe and Needles
3.1.9.1 Introduction
3.1.9.2 Allison Medical
3.1.9.2.1 SureComfort™
3.1.9.3 B. Braun
3.1.9.3.1 Injekt®
3.1.9.3.2 Other Syringe & Needle Offerings
3.1.9.4 Becton Dickinson
3.1.9.4.1 BD™ Insulin Syringes
3.1.9.4.2 BD™ Allergy Syringes
3.1.9.4.3 BD™ Tuberculin Syringes
3.1.9.4.4 BD™ Syringes & Needles
3.1.9.4.5 BD PrecisionGlide™ Needles
3.1.9.4.6 BD Safety-Lok™ Syringes
3.1.9.4.7 BD SafetyGlide™ Syringes & Needles
3.1.9.4.8 BD Eclipse™ Needles and Syringes
3.1.9.4.9 BD Integra™ Needles and Syringes
3.1.9.4.10 BD AutoShield™
3.1.9.4.11 Ultra-Fine™
3.1.9.5 Cardinal Health
3.1.9.5.1 Cardinal Health™
3.1.9.6 Delta Hi-Tech, Inc.
3.1.9.6.1 AIMSCO®
3.1.9.7 Medical Plastic Devices, Inc.
3.1.9.7.1 Insupen®
3.1.9.8 Medtronic
3.1.9.8.1 Magellan™
3.1.9.8.2 Monoject™
3.1.9.9 MYCO Medical
3.1.9.9.1 Dispovan®
3.1.9.10 Nipro Medical
3.1.9.10.1 Nipro™
3.1.9.11 Novo Nordisk
3.1.9.11.1 NovoFine®
3.1.9.11.2 NovoTwist®
3.1.9.12 Owen Mumford, Inc.
3.1.9.12.1 Unifine®
3.1.9.13 Perrigo
3.1.9.13.1 Clickfine®
3.1.9.14 Protectus Medical Devices
3.1.9.14.1 Protectus®
3.1.9.15 ReliOn
3.1.9.15.1 ReliOn®
3.1.9.16 Retractable Technologies, Inc.
3.1.9.16.1 VanishPoint®
3.1.9.16.2 Patient Safe®
3.1.9.17 Revolutions Medical
3.1.9.17.1 ReVac™
3.1.9.18 Safety 1st Medical
3.1.9.18.1 Safe-1®
3.1.9.19 Smiths Medical
3.1.9.19.1 Needle-Pro®
3.1.9.20 SOL-MILLENNIUM
3.1.9.20.1 SOL-CARE®
3.1.9.20.2 SOL-M™
3.1.9.20.3 SOL-GUARD™
3.1.9.21 STAT Medical Devices
3.1.9.21.1 Super-Fine™
3.1.9.22 Terumo
3.1.9.22.1 SurGuard®
3.1.9.22.2 TERUMO®
3.1.9.23 UltiCare
3.1.9.23.1 UltiCare®
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 November 2015
3.2.2 October 2015
3.2.3 September 2015
3.2.4 August 2015
3.2.5 July 2015
3.2.6 April 2015
3.2.7 March 2015
3.2.8 February 2015
3.2.9 January 2015
3.2.10 December 2014
3.2.11 October 2014
3.2.12 September 2014
3.2.13 May 2014
3.2.14 April 2014
3.2.15 March 2014
3.2.16 January 2014
3.2.17 December 2013
3.2.18 September 2013
3.2.19 August 2013
3.2.20 June 2013
3.2.21 March 2013
3.2.22 February 2013
3.2.23 December 2012
3.2.24 August 2012
3.2.25 June 2012
3.2.26 May 2012
3.2.27 March 2012
3.2.28 February 2012
3.2.29 January 2012
3.3 CLINICAL TRIALS
3.3.1 Implantable Port Devices
3.3.2 Central Venous Catheters
3.3.3 Peripherally Inserted Central Catheters
3.3.4 Peripheral Intravenous Catheters
3.3.5 Dialysis Catheters
3.3.6 Ultrasound Vascular Access Devices
3.3.7 Catheter Securement Devices
3.3.8 Syringe and Needles
3.4 PRODUCT PIPELINES
3.4.1 Alliance Vascular Devices, LLC
3.4.1.1 FreeHand Safety Huber Needle®
3.4.2 AngioDynamics
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation
3.4.2.2 Firefly
3.4.2.3 BioFlo® PICC Line Extension
3.4.2.4 BioFlo® Port Line Extension
3.4.2.5 Next Generation BioFlo® PICC
3.4.2.6 Next Generation BioFlo® Port
3.4.3 Bluegrass Vascular Technologies, Inc.
3.4.3.1 Surfacer® Inside-Out™ Access System
3.4.4 C.R. Bard
3.4.4.1 Chemical-Resistant PICCs
3.4.4.2 Novel Advanced Material PICCs
3.4.4.3 PowerGlide® Pro Midline
3.4.4.4 AccuCath®
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter
3.4.4.6 Site~Rite® 8 Ultrasound System
3.4.5 M. C. Johnson
3.4.5.1 PICC Securement Device
3.4.6 Nipro Medical
3.4.6.1 Shielding Safety Needle
3.4.6.2 Safety Syringe
3.4.6.3 Safety PIVC
3.4.7 Parasol Medical
3.4.7.1 Catheter Securement Device
3.4.8 PAVmed Inc.
3.4.8.1 NextCath™
3.4.9 Phase One Medical
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter
3.4.10 Prodigy Diabetes Care, LLC.
3.4.10.1 Insulin Pen Needles
3.4.11 Sharklet Technologies, Inc.
3.4.11.1 Sharklet™ Central Venous Catheter
3.4.12 Starboard Medical
3.4.12.1 Catheter Securement Devices
3.4.13 Teleflex Medical
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports
3.4.14 Vascular Access Technologies, Inc.
3.4.14.1 SAFECVAD™
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP Per Capita
4.1.3 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
ABBREVIATIONS
APPENDIX II: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 – 2023
Chart 1 2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023
Chart 3 1: Central Venous Catheter Market Segments, 2015
Chart 4 1: Country Profile, Germany, 2016
Chart 4 2: Country Profile, France, 2016
Chart 4 3: Country Profile, United Kingdom, 2016
Chart 4 4: Country Profile, Italy, 2016
Chart 4 5: Country Profile, Spain, 2016
Chart 4 6: Country Profile, Benelux, 2016
Chart 4 7: Country Profile, Scandinavia, 2016
Chart 4 8: Country Profile, Austria, 2016
Chart 4 9: Country Profile, Switzerland, 2016
Chart 4 10: Country Profile, Portugal, 2016
List of Figures
Figure 1 1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 2)
Figure 1 2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2016
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013 – 2016
Figure 1 6: Vascular Access Procedures Covered, Europe, 2016
Figure 1 7: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (1 of 3)
Figure 1 8: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (2 of 3)
Figure 1 9: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (3 of 3)
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Class 2 Device Recall Medtronic
Figure 3 2: Class 2 Device Recall Smiths Medical
Figure 3 3: Class 2 Device Recall Arrow
Figure 3 4: Class 2 Device Recall Arrow
Figure 3 5: Class 2 Device Recall Covidien (Medtronic)
Figure 3 6: Class 2 Device Recall Arrow
Figure 3 7: Class 2 Device Recall Medline
Figure 3 8: Class 2 Device Recall Arrow
Figure 3 9: Class 2 Device Recall B. Braun
Figure 3 10: Class 3 Device Recall Bard Access
Figure 3 11: Class 2 Device Recall Covidien (Medtronic)
Figure 3 12: Class 2 Device Recall Bard Access
Figure 3 13: Class 2 Device Recall Bard Access
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics
Figure 3 15: Class 2 Device Recall Bard Access
Figure 3 16: Class 2 Device Recall Arrow
Figure 3 17: Class 2 Device Recall Medcomp
Figure 3 18: Class 2 Device Recall Arrow
Figure 3 19: Class 2 Device Recall Arrow
Figure 3 20: Class 2 Device Recall Smiths Medical
Figure 3 21: Class 2 Device Recall PFM Medical
Figure 3 22: Class 2 Device Recall PFM Medical
Figure 3 23: Class 2 Device Recall Becton Dickinson
Figure 3 24: Class 2 Device Recall Arrow
Figure 3 25: Class 2 Device Recall Arrow
Figure 3 26: Class 2 Device Recall Navilyst Medical
Figure 3 27: Class 2 Device Recall Argon Medical
Figure 3 28: Class 2 Device Recall Arrow
Figure 3 29: Class 2 Device Recall Arrow
Figure 3 30: Class 2 Device Recall Arrow
Figure 3 31: Class 2 Device Recall Bard Access
Figure 3 32: Class 2 Device Recall Navilyst Medical
Figure 3 33: Class 2 Device Recall Bard Access
Figure 3 34: Class 2 Device Recall Smiths Medical
Figure 3 35: Class 2 Device Recall B. Braun
Figure 3 36: Class 2 Device Recall Smiths Medical
Figure 3 37: Class 2 Device Recall Access Scientific
Figure 3 38: Class 2 Device Recall Covidien (Medtronic)
Figure 3 39: Class 2 Device Recall Arrow
Figure 3 40: Class 2 Device Recall Bard Access
Figure 3 41: Class 2 Device Recall Becton Dickinson
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 43: Class 2 Device Recall Bard Access
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 45: Class 2 Device Recall Medcomp
Figure 3 46: Class 2 Device Recall Becton Dickinson
Figure 3 47: Class 3 Device Recall Bard Access
Figure 3 48: Class 2 Device Recall Medcomp
Figure 3 49: Class 1 Device Recall Arrow
Figure 3 50: Class 2 Device Recall Arrow
Figure 3 51: Class 2 Device Recall Vygon
Figure 3 52: Class 2 Device Recall Covidien (Medtronic)
Figure 3 53: Class 2 Device Recall Medcomp
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 55: Class 2 Device Recall Christie Medical Holdings
Figure 3 56: Class 3 Recall Bard Access
Figure 3 57: Class 2 Device Recall AngioDynamics
Figure 3 58: Class 2 Device Recall Becton Dickinson
Figure 3 59: Class 2 Device Recall AngioDynamics
Figure 3 60: Class 2 Device Recall AngioDynamics
Figure 3 61: Class 3 Device Recall AngioDynamics
Figure 3 62: Class 2 Device Recall AngioDynamics
Figure 3 63: Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment
Figure 3 64: A Pragmatic Randomized Trial
Figure 3 65: Assessment of a Power Injectable vs. a Non-Power Injectable
Figure 3 66: Vascular Access in Cancer Patients
Figure 3 67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection
Figure 3 68: Central Line Placement Study
Figure 3 69: The Effects of Anti-infective Central Venous Catheter (CVC)
Figure 3 70: The Use of Point of Care Ultra Sound
Figure 3 71: Complications Associated With Central Venous Access
Figure 3 72: Impact of Ultrasound Guided Central Venous Catheterization
Figure 3 73: Randomized, Prospective, Single-center Study
Figure 3 74: Remifentanil and Local Anesthesia
Figure 3 75: Dissemination of a Simulation-based Mastery Learning Curriculum
Figure 3 76: Incidence of Complication
Figure 3 77: Comparison of Two Needle Insertion Techniques
Figure 3 78: A Monocenter Prospective Study
Figure 3 79: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography
Figure 3 80: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation
Figure 3 81: Use of Chlorhexidine-gel-Impregnated Dressing Compared to Transparent Polyurethane Film Dressing
Figure 3 82: Vascular Access in Hematological Patients
Figure 3 83: Developing and Maintaining a Central Venous Catheter Registry
Figure 3 84: Reliability of Central Venous Pressure Measurements
Figure 3 85: SUBclavian Central Venous Catheters Guidance and Examination by UltraSound
Figure 3 86: Chlorhexidine Containing IV-securement Dressings
Figure 3 87: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters
Figure 3 88: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters
Figure 3 89: Ultrasound Guided Diagnosis of Central Venous Catheters in Children
Figure 3 90: Real-time Ultrasound-guided Catheterization of the Axillary Vein in the Intensive Care Unit
Figure 3 91: Determination of Anatomic Variations of the Internal Jugular and Femoral Veins
Figure 3 92: Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization
Figure 3 93: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement
Figure 3 94: Interest of Ultrasound Coupled to a Guidance System (GPS)
Figure 3 95: Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement
Figure 3 96: Comparison of the Central Venous Catheter Insertion Techniques
Figure 3 97: A Multicenter, Open-label, Randomised, Clinical Trial
Figure 3 98: A Pragmatic Randomized Trial Standard of Care Vascular Access Strategies
Figure 3 99: PICC and Midline Related Complications: A Multicenter Observational Study
Figure 3 100: Complications Associated With Central Venous Access
Figure 3 101: Evaluation of Electrocardiographic Guidance
Figure 3 102: Phase II Randomised Study Comparing the Tolerance of PICC Line
Figure 3 103: Randomized, Prospective, Single-center Study
Figure 3 104: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion
Figure 3 105: Ultrasound-guided Peripheral Vascular Access
Figure 3 106: Vascular Access in Cancer Patients
Figure 3 107: A Monocenter Prospective Study
Figure 3 108: Vascular Access in Hematological Patients
Figure 3 109: ECG Versus Ultrasound-guided Positioning of the Peripherally Inserted Central Catheter (PICC) Tip
Figure 3 110: Sequential Pneumatic Compression
Figure 3 111: Reliability of Central Venous Pressure Measurements
Figure 3 112: Time and Motion Related to PICC Insertion Process and Catheter Tip Confirmation
Figure 3 113: A Randomized Open-labeled Multicenter Study
Figure 3 114: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters
Figure 3 115: A Randomized Prospective Multicenter Evaluation
Figure 3 116: Randomized Double Blind Comparison
Figure 3 117: An Observational, Prospective, Single-center Study of Placement and Confirmation
Figure 3 118: PICC and Midline Related Complications
Figure 3 119: Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses
Figure 3 120: A Comparison of Accuvein to Standard Intravenous Access
Figure 3 121: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
Figure 3 122: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Figure 3 123: Ultrasound-guided Peripheral Vascular Access in Children
Figure 3 124: Preventing Delay of Care in Patient With Difficult IV Access
Figure 3 125: A Randomized Control Trial of Ultrasound Guided IV Access
Figure 3 126: Removal Peripheral Intravenous Catheters According to Clinical Signs
Figure 3 127: Clinical Investigation Acc. to MPG §23b
Figure 3 128: Evaluation of Accuvein® in Obese Patients
Figure 3 129: A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device
Figure 3 130: Technique for Successful Ultrasound-guided Peripheral Vascular Access
Figure 3 131: A Randomized Controlled Open Label Trial
Figure 3 132: A Prospective Feasibility Trial of AccuCath® 2.25 BC Intravascular Catheter System
Figure 3 133: The Use of a Topical Anesthetic Skin Refrigerant
Figure 3 134: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein® IV Catheter
Figure 3 135: Observational Study of the Sonic Window™ Handheld Ultrasound System
Figure 3 136: Near-Infrared Software Performance Study
Figure 3 137: A Randomized Controlled Trial To Compare The Initial Success Rate
Figure 3 138: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
Figure 3 139: Ultrasound Guided Peripheral Intravenous Catheter Insertion
Figure 3 140: Nurse Peripheral Intravenous Catheter Insertion Success
Figure 3 141: ACCESS HD Pilot
Figure 3 142: Randomized Controlled Trial of Straight Versus Coiled Peritoneal Dialysis
Figure 3 143: Randomized Trial Comparing VectorFlow™ Tunneled Dialysis Catheter
Figure 3 144: Duration and Adverse Events of Non-cuffed Catheter
Figure 3 145: Vascular Access Choice and Outcomes in the Elderly and Very Elderly
Figure 3 146: Prevention of Tunneled Cuffed Catheter Malfunction
Figure 3 147: Analysis of CRBSI
Figure 3 148: A Prospective Multicenter Investigation
Figure 3 149: Comparison of an Intensive Versus a Standard Hemodialysis Central Venous Catheter
Figure 3 150: Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter for Dialysis
Figure 3 151: Comparison of Self-locating Catheter Versus a Straight Catheter for Outflow Problems
Figure 3 152: Multi-Center, Prospective, Randomized, Open-Label, Sponsor-Blinded, Active-Control (Heparin) Clinical Investigation
Figure 3 153: Comparative Effectiveness of 30% Trisodium Citrate and Heparin Lock Solutions
Figure 3 154: The Use of Point of Care Ultra Sound for Correct Placement
Figure 3 155: Contribution of Ultrasound for Peripheral Intravenous Catheter
Figure 3 156: Evaluation of Electrocardiographic Guidance
Figure 3 157: Impact of Ultrasound Guided Central Venous Catheterization
Figure 3 158: A Comparison of Accuvein to Standard Intravenous Access
Figure 3 159: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
Figure 3 160: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Figure 3 161: Incidence of Complication Depending on the Cannulation Site
Figure 3 162: A Randomized Controlled Trial Comparing Ultrasound Guided PICC Line Insertion
Figure 3 163: Ultrasound-guided Peripheral Vascular Access in Children
Figure 3 164: Preventing Delay of Care in Patient With Difficult IV Access
Figure 3 165: Ultrasound-guided Peripheral Vascular Access
Figure 3 166: A Randomized Co

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report